ERVFC1-1

Model summary

A cell-surface fusogenic glycoprotein that is essential for terminal stages of muscle formation. It is synthesized via the secretory pathway and displayed at the plasma membrane, where it binds partner proteins and undergoes conformational changes that promote membrane merger between adjacent myogenic cells. By assembling at fusion-competent membrane microdomains and trafficking through vesicular/extracellular routes, it drives multinucleated myotube formation and coordinates with adhesion and vesicle machinery to complete myoblast fusion.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture: a single annotated region, IPR018154 (TLV/ENV coat polyprotein family) spanning residues 232–525.

   This family signature marks retroviral envelope glycoproteins that are synthesized as a polyprotein and then proteolytically matured into an N-terminal receptor-binding ectodomain and a C-terminal transmembrane fusion module. The placement of this ENV-like module in the C-terminal half implies an upstream signal peptide and secretory pathway entry, followed by a luminal/extracellular ectodomain and a downstream single-pass transmembrane region that anchors the complex at the cell surface. This architecture causes avid protein–protein interactions through the ectodomain and intracellular/cytoplasmic tails, supporting GO:0005515 protein binding as the molecular function.

2. 02

   ENV-like fusogens drive membrane merger by first binding a surface receptor and then undergoing large conformational transitions that force membrane apposition and fusion.

   In muscle lineage cells, such fusogenic activity directly enables syncytium formation. This causal chain—from a fusogenic ENV-like core to membrane merger—maps to the biological processes formalized as GO:0000768 syncytium formation by plasma membrane fusion and GO:0007520 myoblast fusion. The same fusogenic logic explains why this protein is essential for terminal myogenesis: coordinated membrane remodeling and cell–cell adhesion transitions culminate in multinucleated myotubes.

3. 03

   The cellular geography follows from the secretory/fusogenic architecture and the provided localization.

   The ENV-like module dictates a primary residence at the plasma membrane and cell surface, aligning with GO:0005886 plasma membrane and GO:0009986 cell surface. Trafficking through endosomal/extracellular vesicle routes is typical for fusogens and explains detection in GO:0070062 extracellular exosome. Storage and mobilization via specialized secretory granules is consistent with GO:0070821 tertiary granule membrane and GO:0101003 ficolin-1-rich granule membrane, which together suggest regulated exocytosis and surface upregulation. Altogether, the membrane-anchored, secretory-pathway-derived architecture accounts for the observed compartmental distribution.

4. 04

   Mechanistically, the ENV-like ectodomain likely binds a yet-unidentified cell-surface partner to trigger fusogenic activation, while the transmembrane/cytoplasmic tail organizes signaling and trafficking that concentrate the fusogen at fusion-competent membrane microdomains.

   I hypothesize that the protein forms transient complexes with fusogenic and adhesion machinery: tetraspanins (CD9/CD81) to scaffold membrane platforms; integrins to couple adhesion and fusion; and fusogens such as syncytin–MBL family or the endogenous fusogenic factor Myomaker (TMEM88B). These assemblies would localize and activate the fusogen at myoblast–myoblast interfaces, driving efficient membrane merger during terminal myogenesis.